Equities

JSP Pharmaceutical Manufacturing (Thailand) PCL

JSP Pharmaceutical Manufacturing (Thailand) PCL

Actions
  • Price (THB)2.42
  • Today's Change0.02 / 0.83%
  • Shares traded317.50k
  • 1 Year change-24.38%
  • Beta--
Data delayed at least 15 minutes, as of Jun 07 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

JSP Pharmaceutical Manufacturing (Thailand) PCL is a Thailand-based company, which manufactures and distributes conventional medicines. The Company manufactures and distributes products under customer’s brand name (OEM), as well as under the Company’s brand name. The Company develops, manufactures and sells conventional and traditional medicines, herbal products and dietary supplements, providing a range of services covering the manufacturer and the seller of the products under both customers’ trademark (OEM) and the seller of the products under the Company’s trademark (Own Brand). The Company develops herbal products, dietary supplements with natural extracts and plant-based protein under brand name Supap Osot, and dietary supplements such as using new raw materials or having new production process for both beauty and health under brand name EVITON. The Company’s subsidiary, Caresutic Co., Ltd., is engaged in manufacturing and distribution of dietary supplements and cosmetic products.

  • Revenue in THB (TTM)611.29m
  • Net income in THB-5.59m
  • Incorporated2018
  • Employees340.00
  • Location
    JSP Pharmaceutical Manufacturing (Thailand) PCL255257 Soi. Sathupradit 58,, Bangpongpang,BANGKOK 10120ThailandTHA
  • Phone+66 22841218
  • Fax+66 22940705
  • Websitehttps://www.jsppharma.com/th/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
LTR Pharma Ltd-2.42tn-2.42tn1.09bn----14.20----------0.0451----------------------------0.00---100.00---41.65------
Immuno-Biological Laboratories Co., Ltd.191.78m43.84m1.10bn60.0025.143.71--5.7520.0520.0587.69135.860.5350.93584.53--12.23-13.9714.68-16.3963.3457.7322.86-39.233.65--0.1572--2.780.8924164.44------
OncoTherapy Science, Inc.143.27m-302.48m1.12bn60.00--12.31--7.85-6.09-6.092.871.620.5139.087.69---108.31-55.67-182.73-63.82-29.13-1.49-211.13-247.472.07-189.930.232---46.2416.81-15.15---48.33--
JSP Pharmactcl Mnfctrng (Thailand) PCL611.29m-5.59m1.13bn340.00--1.3014.971.85-0.0068-0.00681.331.830.45724.217.97--1.722.212.032.7625.0829.813.774.240.7495--0.2473--34.3410.5392.74--26.55--
Wai Yuen Tong Medicine Holdings Limited6.40bn171.56m1.16bn1.96k7.200.11471.430.18050.03030.03031.131.900.20140.42422.81700,208.600.8907-0.07331.54-0.119649.0842.524.42-0.4560.56631.490.31960.00-7.558.7581.16---12.06--
Kringle Pharma Inc18.30m-212.47m1.16bn13.00--2.03--63.27-159.92-159.9213.58356.640.027--2.805,994,308.00-31.29-19.00-33.20-20.23-----1,161.12-156.5112.85--0.00---82.33---157.41------
Data as of Jun 07 2024. Currency figures normalised to JSP Pharmaceutical Manufacturing (Thailand) PCL's reporting currency: Thai Baht THB
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.